Health Idea Now
Thursday, 28 March 2019
Daiichi Sankyo, AstraZeneca sign $6.9 billion cancer drug deal
AstraZeneca Plc and Japan's Daiichi Sankyo Co Ltd have signed a potential multibillion-dollar collaboration to develop and sell Daiichi's cancer drug trastuzumab deruxtecan.
from Reuters: Health News https://ift.tt/2HYGXDQ
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment